Montis Biosciences
Montis Biosciences • Beyond complement
Leuven, Belgium · $9.1M raised
- Headquarters
- Leuven
- Business Model
- B2B
- Website
- montisbio.com
- Total Funding
- $9.1M
- Last Round
- $9.1M SeedFeb 2025
- Rounds
- 1
About
Montis Biosciences develops cutting-edge C1q-targeting antibody therapies for neuroinflammatory diseases and cancer.
Summary
Montis Biosciences is a Biotech company based in Leuven, Belgium. It has raised $9.1M in total across 1 round, most recently a $9.1M Seed round in Feb 2025. Investors include Polaris Partners, 3E Bioventures Capital and Takeda (JP).
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/montis-biosciences"><img src="https://indexed.vc/api/badge/company/montis-biosciences" alt="Montis Biosciences on Indexed.vc" width="260" height="76" /></a>